Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

May 29, 2018

Clinical trial investigates stem cell therapies for spinal cord injuries

By Jen Schutz

Mayo Clinic neurosurgeon, Mohamad Bydon, M.D., is a research grant recipient from Regenerative Medicine Minnesota. His clinical trial investigates whether adipose-derived (fat tissue-derived) mesenchymal stem cells can be safely administered into the cerebrospinal fluid of patients with traumatic spinal cord injury and what the effects this may have on functional improvement, activities of daily living, and quality of life.

If successful, this study may create a viable clinical option for spinal cord injury patients by establishing feasibility and safety data for patients who do not have many treatment options.

Watch the video below to learn more about his research:

Tags: Awards, Center for Regenerative Medicine, clinical trials, Innovations, Mohamad Bydon, Regenerative Medicine Minnesota, republished

Please sign in or register to post a reply.
Contact Us · Privacy Policy